1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Analgesics in Brazil

Analgesics in Brazil

  • September 2016
  • -
  • Euromonitor International
  • -
  • 31 pages

Analgesics was the most important category in consumer health in Brazil in 2016, accounting for 36% of overall OTC value sales. During the same year, the category posted current value growth of 9% to reach sales of B$6.0 billion, although this was a slower performance than the review period current value CAGR of 11%. This slowdown can be mainly attributed to the economic recession in Brazil, which is having a significant negative impact on consumer confidence.

Euromonitor International’s Analgesics in Brazil report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2011-2015, allowing you to identify the sectors driving growth. Forecasts to 2020 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Table Of Contents

Analgesics in Brazil
ANALGESICS IN BRAZIL
Euromonitor International
September 2016

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Analgesics by Category: Value 2011-2016
Table 2 Sales of Analgesics by Category: % Value Growth 2011-2016
Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2011-2016
Table 4 NBO Company Shares of Analgesics: % Value 2012-2016
Table 5 LBN Brand Shares of Analgesics: % Value 2013-2016
Table 6 Forecast Sales of Analgesics by Category: Value 2016-2021
Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2016-2021
Bayer (brasil) SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 1 Bayer (Brasil) SA: Key Facts
Competitive Positioning
Summary 2 Bayer (Brasil) SA: Competitive Position 2016
Boehringer Ingelheim Do Brasil Química E Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 3 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Key Facts
Competitive Positioning
Summary 4 Boehringer Ingelheim do Brasil Química e Farmacêutica Ltda: Competitive Position 2016
Ems SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 5 EMS SA: Key Facts
Competitive Positioning
Summary 6 EMS SA: Competitive Position 2016
Hypermarcas SA in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 7 Hypermarcas SA: Key Facts
Summary 8 Hypermarcas SA: Operational Indicators
Competitive Positioning
Summary 9 Hypermarcas SA: Competitive Position 2016
Sanofi-aventis Farmacêutica Ltda in Consumer Health (brazil)
Strategic Direction
Key Facts
Summary 10 Sanofi-Aventis Farmacêutica Ltda: Key Facts
Competitive Positioning
Summary 11 Sanofi-Aventis Farmacêutica Ltda: Competitive Position 2016
Executive Summary
Economic Slowdown Persists, Affecting Non-priority Categories More Intensely
Increasing Acceptance of Self-medication/self-care Due To Broadened Accessibility
Aggressive Pricing of Private Label Products Threatens the Competitiveness of Manufacturers
Sports Nutrition Manufacturers Expand Their Portfolios and Invest in Segmentation
Consumer Health Is Expected To Grow at A Slower Pace Over the Forecast Period
Key Trends and Developments
OTC Performs Relative Well During the Economic Slowdown As Growth Rates Slow
Health and Wellness Trend Dips As Prioritisation of Spending Negative Influences Sales of Vitamins and Dietary Supplements
Affordability Gains More Importance in the Strategies of Manufacturers
Market Indicators
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2011-2016
Table 9 Life Expectancy at Birth 2011-2016
Market Data
Table 10 Sales of Consumer Health by Category: Value 2011-2016
Table 11 Sales of Consumer Health by Category: % Value Growth 2011-2016
Table 12 NBO Company Shares of Consumer Health: % Value 2012-2016
Table 13 LBN Brand Shares of Consumer Health: % Value 2013-2016
Table 14 Distribution of Consumer Health by Format: % Value 2011-2016
Table 15 Distribution of Consumer Health by Format and Category: % Value 2016
Table 16 Forecast Sales of Consumer Health by Category: Value 2016-2021
Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2016-2021
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Definitions
Sources
Summary 12 Research Sources












View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

Global Over The Counter (OTC) Drugs Market - Segmented by Product Category (Cough, Cold and Flu Products, Analgesics, Dermatological Products, Gastrointestinal Products, Vitamin

  • $ 4250
  • Industry report
  • November 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Global Over the Counter (OTC) Drugs Market

Global Over the Counter (OTC) Drugs Market

  • $ 4250
  • Industry report
  • December 2016
  • by Mordor Intelligence LLP

The global market for over-the-counter (OTC) drugs valued at USD 120 billion and is estimated to scale up to USD 133.25 billion by the end of 2016. Considering the historical trend and possible future ...

Otc Drugs Markets In China

January 2017 $ 4000

Otc Drugs Companies In China

January 2017 $ 1800

Download Unlimited Documents from Trusted Public Sources

OTC Industry in Japan

  • February 2017
    8 pages
  • Vitamin  

  • Japan  

View report >

The future of the Pain Relief Industry in the UK

  • February 2017
    5 pages
  • Pain Relief  

  • United Kingdom  

View report >

OTC Industry in Spain

  • February 2017
    4 pages
  • Vitamin  

  • Spain  

View report >

Otc Supply In The Us

10 days ago

Related Market Segments :

OTC
Vitamin

ref:plp2016

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.